Mail & Guardian
Mail & Guardian
glaxosmithklinelatest news & developments
British pharmaceutical group GlaxoSmithKline (GSK) logged slumping annual profits after the prior year was boosted by asset sales.  (Photo by Tannen Maury/Bloomberg via Getty Images)

Drugmaker GlaxoSmithKlin logs slumping annual profits

Profit after tax sank to just under £4.4-billion (R91.21-billion) last year, the GSK said in a statement on Wednesday

SA, UK spearhead R500-million fund for joint scientific research

The two countries have set up the Newton Fund to focus on areas such as food security, the environment, and disease prevention and control.

Motsoaledi launches free HPV vaccine for schoolgirls

Health Minister Aaron Motsoaledi has launched an HPV vaccine programme for grade four girls in all government schools.

The research builds on previous trials showing that people who take a small daily doses of antiretroviral drugs can reduce their risk of being infected.

HIV research on monkeys makes breakthrough

A single shot of antiretroviral drugs has protected lab monkeys from HIV for weeks, according to two US trials.

There’s a new HIV drug – but Africa will have to wait

A new drug, Tivicay, that could be vital in the struggle against HIV, might not be available to those who need it the most.

Drug resistant Chinese bird flu raises concern

The new bird flu strain that has killed 36 people has proved resistant to Tamiflu for the first time, a development scientists find "concerning".

Pharmaceutical industry targets Africa’s growing middle class

According to data, by 2016 pharmaceutical spending in Africa is expected to reach $30-billion – driven by the continent’s increasing economic wealth.

The government plans to vaccinate 10-year-old girls against the human papillomavirus.

Cervical cancer can be prevented

Cervical cancer is caused by a very common virus, but it is easy to detect and there is a vaccination for it, writes Mia Malan

Drug companies are buying the opinion of doctors

Exposed: Bitter pill of bad pharma

A new book detailing how profit-hungry pharmaceutical companies mislead medical practitioners and harm patients may be just what the doctor ordered.

Peddling myths: GlaxoSmithKline chief executive Andrew Witty said the company had learnt from its mistakes.

Pharmaceutical giant regrets corporate misconduct

GlaxoSmithKline has been fined $3-billion after admitting to encouraging the prescription of unsuitable antidepressants to children.

Identifying South Africa’s silent killers

Diseases with little or no symptoms are silently killing South Africans.

Breast is best – for slim adults

Breast is best – for slim adults

Exclusively breastfed babies are less likely to become obese adults, research has shown.

Big Pharma backs deal to boost flu pandemic readiness

Virus samples will be shared globally in exchange for vaccines produced from them under a landmark deal to improve preparedness for a flu pandemic.

GlaxoSmithKline urged to pool its patents on HIV drugs

Leading UK and international organisations have written to Britain’s largest drug company urging it to pool its patents on HIV medicines.

Roche defends diet drug as FDA probes liver claim

There is no evidence of a link between weight loss drug Xenical and liver injury, drugmaker Roche said on Tuesday.

Bill Gates in new push against malaria

Bill Gates and thousands of babies are helping Africa prepare its largest medical experiment ever in the search for a new vaccine against malaria.

NatWest Three may plea bargain over Enron charges

Three British bankers whose extradition to the United States caused a political storm last year are on the brink of a plea agreement that could involve an admission of wrongdoing…

Malaria vaccine shows promise in infants

A malaria vaccine currently under development can be safely given to young infants and appears to offer strong protection against the disease, according to the results of a study…